SEC Form 4 · accession 0001209191-15-063389
Ampio Pharmaceuticals, Inc. · AMPE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory A Gould
Officer — Chief Financial Officer
Period of report
Jul 30, 2015
Accepted (ET)
Aug 3, 2015 · 8:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411906
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.60 | Jul 30, 2015 | A | 100,000 | A | — | Jul 30, 2025 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable in three equal installments. 1/3rd of the shares shall vest on the grant date (July 30, 2015); 1/3rd of the shares shall vest on July 30, 2016 and 1/3rd of the shares shall vest on July 30, 2017.